SIB Innovations- und Beteiligungsgesellschaft
VC Fund
Dresden, Germany
SIB Innovations- und Beteiligungsgesellschaft is a VC fund in Dresden focused on Medical and Lighting. SIB is a investment company that provides its clients with equity financing solutions and services.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries SIB Innovations- und Beteiligungsgesellschaft invests in
Stages SIB Innovations- und Beteiligungsgesellschaft invests in
Countries SIB Innovations- und Beteiligungsgesellschaft invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
|
|||
Investment Focus
Industry
- Medical 1 (33%)
- Lighting 1 (33%)
- Software 1 (33%)
- Wellness 1 (33%)
- Marketing 1 (33%)
Stage
- Series B 2 (67%)
- Series A 1 (33%)
Country
- Germany 2 (67%)
- United States 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Christian Muller
Managing directors
|
Managing directors | Total investments: 0 | Find email | |
|
Matthias Kalbus
Beteiligungsmanager
|
Beteiligungsmanager | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Tasso is revolutionizing blood-based diagnostics by placing the user at the center of the diagnostics process. Patients are able to sample their own blood in the comfort of their home with a device that is safe, simple, and convenient. | $100M / Series B / Dec 16, 2021 | |
|
|
MediaInterface designs and develops software for speech recognition. The company was founded in 1997 and is based in Dresden, Germany. | $1.3M / Series A / Dec 20, 2006 | |
|
|
Novaled AG is a world-class technology provider in organic light-emitting diode (OLED) technologies. With expertise in synthetic and analytical chemistry, it offers complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials.Novaled has developed long-term partnerships with major OLEDplayers worldwide. Its strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia. | $16.5M / Series B / Dec 01, 2005 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does SIB Innovations- und Beteiligungsgesellschaft invest in?
SIB Innovations- und Beteiligungsgesellschaft invests primarily in Medical, Lighting and Software startups, most often at Series B and Series A stage. Most of the 3 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact SIB Innovations- und Beteiligungsgesellschaft?
Public channels for SIB Innovations- und Beteiligungsgesellschaft include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SIB Innovations- und Beteiligungsgesellschaft?
The team at SIB Innovations- und Beteiligungsgesellschaft includes Christian Muller (Managing directors) and Matthias Kalbus (Beteiligungsmanager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!